Studies have shown that ATM knockdown inhibits drug-induced CHK1 and ERK1/2 phosphorylation and enhances the cytotoxicity of PARPi and CHK1i on tumor cells (63) Prexasertib (LY2603618) is the first selective CHK1/2 inhibitor. The gene discussed is CHEK1; the disease is neoplasm.